KRBP Annual Current Liabilities
$20.38 M
+$7.09 M+53.41%
31 December 2023
Summary:
As of January 23, 2025, KRBP annual total current liabilities is $20.38 million, with the most recent change of +$7.09 million (+53.41%) on December 31, 2023. During the last 3 years, it has risen by +$18.91 million (+1288.55%). KRBP annual current liabilities is now at all-time high.KRBP Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KRBP Quarterly Current Liabilities
$19.13 M
+$2.07 M+12.15%
30 September 2024
Summary:
As of January 23, 2025, KRBP quarterly total current liabilities is $19.13 million, with the most recent change of +$2.07 million (+12.15%) on September 30, 2024. Over the past year, it has increased by +$2.07 million (+12.15%). KRBP quarterly current liabilities is now -6.13% below its all-time high of $20.38 million, reached on December 31, 2023.KRBP Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KRBP Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +53.4% | +12.2% |
| 3 y3 years | +1288.5% | +2.3% |
| 5 y5 years | +3236.9% | +2.3% |
KRBP Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +497.6% | -6.1% | +461.0% |
| 5 y | 5-year | at high | +2924.8% | -6.1% | +2739.4% |
| alltime | all time | at high | +3236.9% | -6.1% | +2739.4% |
Kiromic BioPharma Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $19.13 M(+12.1%) |
| June 2024 | - | $17.06 M(-10.7%) |
| Mar 2024 | - | $19.09 M(-6.3%) |
| Dec 2023 | $20.38 M(+53.4%) | $20.38 M(+15.5%) |
| Sept 2023 | - | $17.65 M(-5.6%) |
| June 2023 | - | $18.70 M(-5.8%) |
| Mar 2023 | - | $19.86 M(+49.5%) |
| Dec 2022 | $13.28 M | $13.28 M(+19.6%) |
| Sept 2022 | - | $11.11 M(+86.1%) |
| June 2022 | - | $5.97 M(+45.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $4.11 M(+20.4%) |
| Dec 2021 | $3.41 M(+132.3%) | $3.41 M(+136.0%) |
| Sept 2021 | - | $1.44 M(-7.8%) |
| June 2021 | - | $1.57 M(-7.8%) |
| Mar 2021 | - | $1.70 M(+15.8%) |
| Dec 2020 | $1.47 M(+117.8%) | $1.47 M(-34.8%) |
| Sept 2020 | - | $2.25 M(+26.0%) |
| June 2020 | - | $1.79 M(+101.5%) |
| Mar 2020 | - | $886.70 K(+31.6%) |
| Dec 2019 | $673.70 K(+10.3%) | $673.70 K |
| Dec 2018 | $610.70 K | - |
FAQ
- What is Kiromic BioPharma annual total current liabilities?
- What is the all time high annual current liabilities for Kiromic BioPharma?
- What is Kiromic BioPharma annual current liabilities year-on-year change?
- What is Kiromic BioPharma quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Kiromic BioPharma?
- What is Kiromic BioPharma quarterly current liabilities year-on-year change?
What is Kiromic BioPharma annual total current liabilities?
The current annual current liabilities of KRBP is $20.38 M
What is the all time high annual current liabilities for Kiromic BioPharma?
Kiromic BioPharma all-time high annual total current liabilities is $20.38 M
What is Kiromic BioPharma annual current liabilities year-on-year change?
Over the past year, KRBP annual total current liabilities has changed by +$7.09 M (+53.41%)
What is Kiromic BioPharma quarterly total current liabilities?
The current quarterly current liabilities of KRBP is $19.13 M
What is the all time high quarterly current liabilities for Kiromic BioPharma?
Kiromic BioPharma all-time high quarterly total current liabilities is $20.38 M
What is Kiromic BioPharma quarterly current liabilities year-on-year change?
Over the past year, KRBP quarterly total current liabilities has changed by +$2.07 M (+12.15%)